e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Advances in the future treatment of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Carbocisteine attenuates influenza virus A replication in the bronchoalveolar lavage fluids of virus-infected mice
Shuichiro Maruoka (Tokyo, Japan), Shuichiro Maruoka, Sotaro Shikano, Yasuhiro Gon, Kazumichi Kuroda, Kaori Soda, Eriko Tsuboi, Ikuko Takeshita, Kazufumi Shimizu, Shu Hashimoto
Source:
International Congress 2015 – Advances in the future treatment of COPD
Session:
Advances in the future treatment of COPD
Session type:
Oral Presentation
Number:
489
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Shuichiro Maruoka (Tokyo, Japan), Shuichiro Maruoka, Sotaro Shikano, Yasuhiro Gon, Kazumichi Kuroda, Kaori Soda, Eriko Tsuboi, Ikuko Takeshita, Kazufumi Shimizu, Shu Hashimoto. Carbocisteine attenuates influenza virus A replication in the bronchoalveolar lavage fluids of virus-infected mice. Eur Respir J 2015; 46: Suppl. 59, 489
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Assessment of viral load and time course of pulmonary inflammation in a murine model of H1N1 (PR8) influenza virus infection
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Characterization of an acute influenza infection in a murine model of allergic asthma and responses to corticosteroid
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
Regulation of microRNAs in response to herpes simplex virus type-1 (HSV-1) infection in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013
IP-10 is selectively produced in the airways upon respiratory virus infection
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Absence of human rhinovirus and respiratory syncytial virus in the lungs of patients with stable chronic obstructive pulmonary disease
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
Increased uric acid levels in bronchoalveolar lavage fluid of mice infected with H1N1 influenza
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011
Influenza induced exacerbation is associated with steroid insensitive AHR and pulmonary inflammation in HDM-sensitised mice
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
Type I interferons and IL-15 regulate antiviral cellular responses to rhinovirus infection
Source: Annual Congress 2013 –Viral infections: what is new?
Year: 2013
Novel experimental model of maintained acute lung injury
Source: Annual Congress 2013 –Experimental models in critical care
Year: 2013
Broccoli sprout homogenates and live attenuated influenza virus: Effect on peripheral blood natural kill cells
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015
Blood and BAL T cell cytokine production during RV16 infection in normal and asthmatic human volunteers
Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Year: 2005
Involvement of the JAK-STAT3 pathway in a lipopolysaccharide-induced rat model of airway inflammation
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
The effect of influenza virus infection on airway inflammation in a murine model of asthma
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Detection of herpes simplex virus type-1 (HSV-1) in lung tissue and bronchoalveolar lavage fluid (BALF) of patients with fibrotic idiopathic interstitial pneumonias (f-IIPs)
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009
The role of neutrophils in viral clearance during respiratory syncytial virus (RSV) disease
Source: Annual Congress 2013 –Pulmonary infection in children: diagnosis and long-term effects
Year: 2013
Acutely lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016
Effects of infections on lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) after lung transplantation
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016
Did the introduction of pneumococcal vaccination in Italy change the BAL positive cultures in children with chronic lung diseases?
Source: International Congress 2016 – Paediatric bronchology II
Year: 2016
LATE-BREAKING ABSTRACT: RV568, a narrow spectrum kinase inhibitor (NSKI), inhibits virus induced nasal interleukin-8 (IL8) in the human viral challenge model where healthy adult male volunteers were experimentally inoculated with live respiratory syncytial virus
Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment
Year: 2013
Expression of the B cell differentiation factor BAFF and chemokine CXCL13 in a murine model of human respiratory syncytial virus infection
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept